@arecor_plc profile picture
Arecor Therapeutics @arecor_plc

Clinical‑stage biotech developing superior therapies to reduce treatment burden & improve outcomes for people with diabetes, obesity & cardiometabolic diseases

Joined May 2011
  • Tweets 402
  • Following 231
  • Followers 335
203 Photos and videos
Today we are proud to announce the formation of our new Scientific Advisory Board of oral drug delivery experts, including David Brayden, Randall Mrsny, and Christopher Porter. #Arecor #OralPeptides
1
112
Arestat™ is our innovative proprietary formulation technology platform. For it to work, we follow four key steps. To find out how Arestat™ can enhance your product visit: arecor.com/technology/ #Arestat #Arecor #Innovation #Technology
0:21
152
Our CMC Manager, Natalie Meredith, will be attending the SAE Injectable Drug Delivery Conference taking place in London from June 24-25. If you’re attending, come and connect with Natalie! #Arecor #AT278 #InjectableDrugDelivery #CMC
67
Our CEO Sarah Howell and CSO Jan Jezek attended the ADA 85th Scientific Session this weekend, in Chicago. Thomas Pieber presented a poster on AT278, our ultra concentrated, ultra rapid acting insulin. #Arecor #Diabetes #Insulin #Conference
84
Our Formulation Lead, Monish Suratwala, will be attending the 2ndPeptide Formulation & Delivery Innovation Summit in Boston on June 25-26. Learn more about our oral delivery of peptides on our website here: arecor.com/our-portfolio/ora… #Arecor #OralPeptides #Conference
1
67
Dave Gerring, Chief Development Officer, and Jalini Gugagayanan, BD Manager, will be attending BIO International (@IAmBiotech) in Boston from 16-19 June. convention.bio.org/ #Arestat #BIO2025 #Arecor #conference #networking
1
97
Did you know that over 500 million people worldwide live with diabetes, with treatment costs approaching $1 trillion annually? Learn more on Arecor’s work this #DiabetesWeek: arecor.com/our-portfolio/dia… #PatientCare #Arecor
1:02
30
At Arecor we are transforming patient care by developing innovative medicines that address significant unmet patient needs in high-value markets. arecor.com/ #Arestat #Arecor #Innovation #Biotech
0:27
73
This week Katerina Rousou, a scientist from our diabetes and obesity research team, attended the Gattefossé and NextPharma seminar, with talks on enhanced bioavailability and lipid-based formulation techniques. #Arecor #biotech #innovation
1
102
Our CEO Sarah Howell caught up with Stephen Gunnion from @proactive_UK to provide a partnership update following our announcement this week of a new partnership with Skye Bioscience. #Arecor #drugDevelopment #biotech #diabetes
Proactive
@proactive_x
22 May 2025
Arecor CEO on Skye Bioscience partnership and the value of collaborations @arecor_ltd #AIM #AREC ow.ly/fOj71069GOZ
1
65
We’re partnering with Skye Bioscience Inc. to develop a novel, higher concentration formulation of Skye’s CB1 inhibitor, nimacimab, using our #Arestat technology. Learn more here : arecor.com/news/ #Arecor #drugDevelopment #biotech #obesity
2
100
This Thursday at 2pm BST, watch our live full year financial results for the year ended 31 December 2024. Sign up here: investormeetcompany.com/comp… #financialresults #Arecor #drugDevelopment #biotech #diabetes
1
31
Watch the webcast for our full year financial results for the year ended 31 December 2024 here: tinyurl.com/mrxvy697 #financialresults #Arecor #drugDevelopment #biotech #diabetes
34
Our CEO spoke to Stephen Gunnion from Proactive about our recently announced financial results for the year ended 31 December 2024. Watch the interview below to learn more about our key highlights of 2024 and what’s next for Arecor. #Arecor #drugDevelopment #biotech #diabetes
Proactive
@proactive_x
23 Apr 2025
Arecor CEO on strong 2024 progress and 2025 milestones @arecor_ltd #AIM #AREC ow.ly/3UYc1066Kvx
58
Today we announced our financial results for the year ended 31 December 2024 highlighting our progress across the business. To view our 2024 results statement, please visit: otp.tools.investis.com/clien…
20
Our CEO Sarah Howell, CSO Jan Jezek, and CDO David Gerring will be at #ATTD2025 from March 19-22, in Amsterdam, The Netherlands. Interested in connecting during #ATTD2025? Reach out to us at info@arecor.com #Arecor #Biotech #Diabetes #Innovation
1
143
We are delighted to be featured in @businessweekly #Killer50 #Ones2Watch list for 2025. Testament to Arecor’s creative scientists developing innovative enhanced medicines to serve unmet patient needs. #Arecor #Biotech #Innovation
23
We are pleased to announce a formulation development partnership with a clinical-stage biopharmaceutical company developing peptide therapies. Read more here: arecor.com/news/ #Arecor #Biotech #Innovation #Arestat
1
76
Today we've issued a Full Year 2024 Trading Update ahead of our audited financial results in April. Read more here: tinyurl.com/mvxt6htk #Arecor #Biotech #Innovation
81
Today we have announced our intention during 2025 to cease operations of Tetris Pharma, and a mutual agreement with Xeris to return the rights to Ogluo®. Read the full release here: lnkd.in/en2MS6NY #Arecor #Innovation #DrugDevelopment #Biotech
145
Load more